Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-04-17 6:34 pm Purchase | 2025-04-15 | 13D | Allurion Technologies Inc. ALUR | RTW INVESTMENTS LP | 2,542,603 34.100% | 1,492,550 (+142.14%) | Filing History |
| 2025-02-24 4:15 pm Purchase | 2025-02-20 | 13D | Allurion Technologies Inc. ALUR | RTW INVESTMENTS LP | 1,050,053 17.600% | 903,389 (+615.96%) | Filing History |
| 2025-02-14 09:00 am Purchase | 2024-12-31 | 13G | Akero Therapeutics, Inc. AKRO | RTW INVESTMENTS LP | 6,859,823 9.800% | 940,388 (+15.89%) | Filing History |
| 2025-02-14 09:00 am Purchase | 2024-12-31 | 13G | Stoke Therapeutics, Inc. STOK | RTW INVESTMENTS LP | 5,310,033 9.990% | 1,178,988 (+28.54%) | Filing History |
| 2025-02-14 09:00 am Purchase | 2024-12-31 | 13G | Establishment Labs Holdings Inc. ESTA | RTW INVESTMENTS LP | 2,822,216 9.990% | 328,078 (+13.15%) | Filing History |
| 2025-02-14 09:00 am Purchase | 2024-12-31 | 13G | Neurogene Inc. NGNE | RTW INVESTMENTS LP | 1,498,829 9.990% | 363,573 (+32.03%) | Filing History |
| 2025-02-14 09:00 am Purchase | 2024-12-31 | 13G | Milestone Pharmaceuticals Inc. MIST | RTW INVESTMENTS LP | 5,640,593 9.990% | 2,285,768 (+68.13%) | Filing History |
| 2025-02-14 09:00 am Sale | 2024-12-31 | 13G | ACADIA Pharmaceuticals Inc. ACAD | RTW INVESTMENTS LP | 8,705,501 5.200% | -5,002,005 (-36.49%) | Filing History |
| 2025-02-14 09:00 am Sale | 2024-12-31 | 13G | SAB Biotherapeutics, Inc. SABS | RTW INVESTMENTS LP | 1,024,335 9.990% | -8,196,337 (-88.89%) | Filing History |
| 2025-02-14 09:00 am Sale | 2024-12-31 | 13G | ESSA Pharma Inc. EPIX | RTW INVESTMENTS LP | 1,113,002 2.500% | -2,148,494 (-65.87%) | Filing History |
| 2025-02-14 09:00 am Purchase | 2024-12-31 | 13G | PepGen Inc. PEPG | RTW INVESTMENTS LP | 3,193,097 9.800% | 3,193,097 (New Position) | Filing History |
| 2025-02-14 09:00 am Sale | 2024-12-31 | 13G | Taysha Gene Therapies, Inc. TSHA | RTW INVESTMENTS LP | 12,368,334 5.900% | -6,137,222 (-33.16%) | Filing History |
| 2025-02-14 09:00 am Sale | 2024-12-31 | 13G | Dyne Therapeutics, Inc. DYN | RTW INVESTMENTS LP | 5,218,641 5.100% | -1,600,000 (-23.47%) | Filing History |
| 2025-02-14 09:00 am Sale | 2024-12-31 | 13G | Sage Therapeutics, Inc. SAGE | RTW INVESTMENTS LP | 3,002,370 4.900% | -2,194,649 (-42.23%) | Filing History |
| 2025-02-14 09:00 am Sale | 2024-12-31 | 13G | Axsome Therapeutics, Inc. AXSM | RTW INVESTMENTS LP | 4,051,365 8.400% | -438,231 (-9.76%) | Filing History |
| 2025-02-14 09:00 am Sale | 2024-12-31 | 13G | Immatics N.V. IMTX | RTW INVESTMENTS LP | 6,540,540 5.500% | -3,459,460 (-34.59%) | Filing History |
| 2025-02-14 09:00 am Sale | 2024-12-31 | 13G | CUTERA INC CUTRQ | RTW INVESTMENTS LP | 0 0.000% | -1,817,585 (Position Closed) | Filing History |
| 2025-02-14 09:00 am Sale | 2024-12-31 | 13G | Geron Corporation GERN | RTW INVESTMENTS LP | 0 0.000% | -44,111,916 (Position Closed) | Filing History |
| 2025-02-14 09:00 am Purchase | 2024-12-31 | 13G | Apogee Therapeutics, Inc. APGE | RTW INVESTMENTS LP | 2,712,097 6.000% | 2,712,097 (New Position) | Filing History |
| 2025-02-14 09:00 am Purchase | 2024-12-31 | 13G | Spyre Therapeutics, Inc. SYRE | RTW INVESTMENTS LP | 3,621,996 6.200% | 1,389,236 (+62.22%) | Filing History |